Explaining gene and cell therapy

Illustrations for Oxford BioMedica vector technology and Novartis treatments

Our illustrations for Oxford BioMedica's products targeting Parkinson's and ocular disease, and the Novartis CTL-019 for lymphocytic leukemia explain to investors and wider audiences how their cutting edge technology and treatments work.

photography and illustration